Ritter Pharmaceuticals, Inc.
Company

Ritter Pharmaceuticals, Inc.

Pharmaceutical Manufacturing Los Angeles, California, United States 6 employees RTTR
Employees
6
Contacts
2
Emails
2
Phones
1

Ritter Pharmaceuticals, Inc. Overview

Headquarters
Los Angeles, California, United States
Industry
Pharmaceutical Manufacturing
Employees
6
Founded
2004
Stock Symbol
RTTR
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Ritter Pharmaceuticals, Inc.

Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. Its lead product, RP-G28, has the potential to become the first FDA-approved treatment for lactose intolerance, a condition that affects millions worldwide. The company is further exploring and translating the functionality gut microbiome changes may have on improving gut health and its therapeutic potential to treat/prevent a variety of gastrointestinal diseases.

Ritter Pharmaceuticals, Inc. Contact Details

People in AeroLeads
3
With contact data
2
Email contacts
2
66.7% coverage
Phone contacts
1
33.3% coverage

Ritter Pharmaceuticals, Inc. Org Chart

Sample employees and titles
Name Title Contact
Angel Francisco Tovar Martinez Equipamiento Médico Eqmed
Email Phone
Jawhara Aimbetova Jawhara Aimbetova
View
Sandy Malek Lactose Intolerance Product at Lactagen
Email

Employees by Management Level

Individual contributor 3 profiles

Compare Similar Companies to Ritter Pharmaceuticals, Inc.